Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy

Clinical trial NCT00607386 · COMPLETED

Trial details

NCT number: NCT00607386
Sponsor: Shire
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hunter Syndrome Mucopolysaccharidosis II MPS II

Start date: 2007-12-31
Primary completion: 2011-07-08
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.